Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/american-medical-association/placebo-the-unknown-variable-in-a-controlled-trial-P0lWU2uEaY
References (10)
-
P. Doshi, Florence Bourgeois, Kyungwan Hong, Mark Jones, Haeyoung Lee, Larissa Shamseer, O. Spence, T. Jefferson (2020)
Adjuvant-containing control arms in pivotal quadrivalent human papillomavirus vaccine trials: restoration of previously unpublished methodologyBMJ Evidence-Based Medicine, 25
-
R. Webster, J. Howick, T. Hoffmann, H. Macdonald, G. Collins, J. Rees, V. Napadow, C. Madigan, A. Price, S. Lamb, F. Bishop, Klara Bokelmann, A. Papanikitas, N. Roberts, A. Evers (2019)
Inadequate description of placebo and sham controls in a systematic review of recent trialsEuropean Journal of Clinical Investigation, 49
-
Stephen Nicholls, A. Lincoff, Michelle Garcia, Dianna Bash, C. Ballantyne, P. Barter, M. Davidson, J. Kastelein, W. Koenig, D. McGuire, D. Mozaffarian, P. Ridker, K. Ray, B. Katona, A. Himmelmann, Larrye Loss, M. Rensfeldt, Torbjörn Lundström, R. Agrawal, V. Menon, K. Wolski, S. Nissen (2020)
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.JAMA
-
M. Christensen, F. Knop (2012)
The unobtainable placebo: control of independent clinical research by industry?The Lancet, 379
-
B. Golomb, Laura Erickson, Sabrina Koperski, D. Sack, M. Enkin, J. Howick (2010)
What's in Placebos: Who Knows? Analysis of Randomized, Controlled TrialsAnnals of Internal Medicine, 153
-
Lisa Schwartz, S. Woloshin, Zhigang Lu, K. Ross, Frazer Tessema, Doris Peter, A. Kesselheim (2019)
Randomized Study of Providing Evidence Context to Mitigate Physician Misinterpretation Arising From Off-Label Drug Promotion.Circulation: Cardiovascular Quality and Outcomes
-
R. Shader (2017)
Placebos and Clinical Therapeutics.Clinical therapeutics, 39 7
-
Deepak Bhatt, P. Steg, Michael Miller, E. Brinton, T. Jacobson, S. Ketchum, R. Doyle, R. Juliano, L. Jiao, C. Granowitz, J. Tardif, C. Ballantyne (2019)
Cardiovascular Risk Reduction with Icosapent Ethyl for HypertriglyceridemiaThe New England Journal of Medicine, 380
-
P. Ridker, E. Danielson, F. Fonseca, J. Genest, A. Gotto, J. Kastelein, W. Koenig, P. Libby, A. Lorenzatti, Jean Macfadyen, B. Nordestgaard, J. Shepherd, J. Willerson, R. Glynn (2008)
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.The New England journal of medicine, 359 21
-
J. Moncrieff, S. Wessely, R. Hardy (2004)
Active placebos versus antidepressants for depression.The Cochrane database of systematic reviews, 1
- Publisher
- American Medical Association
- Copyright
- Copyright 2021 American Medical Association. All Rights Reserved.
- ISSN
- 2168-6106
- eISSN
- 2168-6114
- DOI
- 10.1001/jamainternmed.2020.8670
- Publisher site
- See Article on Publisher Site
Abstract
This Viewpoint discusses how improper matching of placebos to experimental drugs in controlled trials can lead to underreporting of harms, confounding, and misleading trial outcomes.
Journal
JAMA Internal Medicine – American Medical Association
Published: May 22, 2021